|
시장보고서
상품코드
1558413
세포치료 및 유전자 치료 시장 규모 및 예측, 세계 및 지역 점유율, 동향, 성장 기회 분석 보고서 : 유형별, 서비스별, 규모별, 서비스 프로바이더별, 최종사용자별, 지역별Cell and Gene Therapy Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Services, Scale, Service Providers, End User, and Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세포치료 및 유전자 치료 시장은 2023년 44억 8,500만 달러에서 2031년에는 280억 5,039만 달러로 성장할 것으로 예측되고 있으며, 2023-2031년 CAGR은 25.8%를 기록할 것으로 예측됩니다.
세포 치료 및 유전자 치료 시장 분석에 기여한 주요 부문은 서비스, 규모, 서비스 제공 업체 및 최종사용자입니다.
세포치료 및 유전자치료 시장은 유형별로 세포치료와 유전자치료로 나뉘며, 2023년 시장 점유율은 세포치료 분야가 가장 큰 비중을 차지할 것으로 예상됩니다. 세포 치료는 특정 세포군을 복구 및 변화시키거나 체내에서 치료할 수 있는 세포를 제공함으로써 장애 및 질병을 치료하는 데 도움이 됩니다. 세포 치료는 환자에게 도입하기 전에 체외에서 세포를 형성하거나 변형시킵니다. 세포는 환자 유래(자가 세포) 또는 기증자 유래(동종 세포)일 수 있습니다. 세포치료 분야의 성장은 시장에 진입하는 제품의 수 증가, 자가면역질환, 암, 감염성 질환 치료에 대한 세포치료의 잠재적 적용 가능성, 진행 중인 임상시험의 수 증가 등에 기인합니다.
세포 치료 및 유전자 치료 시장은 서비스별로 공정 개발, cGMP 제조, 규제 서비스, 바이오 분석 서비스로 구분되며, 2023년 시장 점유율은 공정 개발 분야가 가장 큰 비중을 차지할 것으로 예상됩니다. 세포치료 및 유전자치료 시장은 특히 제조 및 전달 서비스의 기술 발전으로 인해 빠르게 성장하고 있습니다. 이러한 발전에 따라 세포치료 및 유전자치료 개발 기업은 견고하고 확장 가능한 제조 공정 개발, 고품질 제품의 일관성 보장, 특정 치료 표적에 대한 전달 방법 최적화에 대한 전문 지식을 제공합니다.
유형에 따라 시장은 통풍형과 비통풍형으로 구분되며, 2023년 시장 점유율은 통풍형이 더 큽니다.
세포치료 및 유전자치료 시장은 규모에 따라 상용화 전/R&D 제조와 상용화 규모 제조로 구분되며, 2023년에는 상용화 전/R&D 제조 분야가 가장 큰 비중을 차지할 것으로 예상됩니다.
세포치료 및 유전자치료 시장은 서비스 프로바이더별로 CDMO와 CMO로 나뉘며, 2023년 시장 점유율은 CDMO 부문이 클 것으로 예상됩니다.
최종사용자별로 세포치료 및 유전자치료 시장을 살펴보면, 시장은 위탁연구기관, 제약-바이오제약기업, 학술-연구기관으로 구분되며, 2023년에는 제약-바이오제약기업 부문이 시장을 장악했습니다.
세포치료 및 유전자치료 시장 조사 보고서는 북미(미국, 캐나다, 멕시코), 유럽(스페인, 영국, 독일, 프랑스, 이탈리아, 기타 유럽), 아시아태평양(한국, 중국, 일본, 인도, 호주, 기타 아시아태평양), 중동 및 아프리카(한국, 중국, 일본, 인도, 호주, 기타 아시아태평양), 중동 및 아프리카( 남아프리카공화국, 사우디아라비아, 아랍에미리트, 기타 중동 및 아프리카), 중남미(브라질, 아르헨티나, 기타 중남미)입니다. 매출액 기준으로는 북미가 2023년 가장 큰 시장 점유율을 차지했습니다. 한편, 아시아태평양은 2023년 가장 빠르게 성장한 세계 세포치료 및 유전자치료 시장을 차지했습니다. 중국은 유전자 및 세포 치료 분야에서 진전을 이루고 있습니다. 중국은 환자 수가 많아 이러한 치료법을 개발하는 기업에게 매력적인 시장으로 부상하고 있습니다. 중국에서는 여러 기업이 암, 유전성 질환과 같은 질병에 대한 혁신적인 치료법을 개발하고 있으며, 유전자 치료 연구개발에 많은 투자를 하고 있습니다. 중국은 2003년 유전자 치료제를 승인한 최초의 국가입니다. 이후 전 세계에서 세포치료와 유전자치료의 개발이 급속히 발전하고 있으며, 그 치료 잠재력이 급상승하고 있습니다. 중화인민공화국 정부는 세포치료와 유전자치료의 규범적 발전을 촉진하기 위해 여러 가지 규제 개혁을 단행했습니다. 또한 각 분야에서 사업을 운영하는 다양한 시장 리더의 존재는 시장 확대에 기여하고 있으며, 이는 세포치료 및 유전자치료 시장 규모 확대에 크게 기여하고 있습니다.
유럽연합(EU), 경제협력개발기구(OECD), 국립의학도서관(NLM)은 세포치료 및 유전자치료 시장에 대한 보고서를 작성할 때 참고한 1차 및 2차 정보 중 일부입니다.
목차
제1장 서론
제2장 개요
- 주요 인사이트
제3장 조사 방법
- 2차 조사
- 1차 조사
- 가설 책정
- 거시경제 요인 분석
- 기초 수치 작성
- 데이터 삼각측량
- 국가 레벨 데이터
제4장 세포치료 및 유전자 치료 시장 구도
- PEST 분석
제5장 세포치료 및 유전자 치료 시장 : 주요 시장 역학
- 세포치료 및 유전자 치료 시장 - 주요 시장 역학
- 시장 성장 촉진요인
- 세포치료 및 유전자 치료의 승인 건수의 증가
- 세포치료 및 유전자 치료 제조 아웃소싱의 급속한 보급
- 시장 성장 억제요인
- 세포치료 및 유전자 치료 제조의 고비용
- 시장 기회
- 기업에 의한 전략적 구상
- 향후 동향
- 세포치료 및 유전자 치료 제조 서비스의 자동화
- 촉진요인과 억제요인의 영향
제6장 세포치료 및 유전자 치료 시장 : 세계 시장 분석
- 세포치료 및 유전자 치료 시장 매출, 2021-2031년
- 세포치료 및 유전자 치료 시장 예측 분석
제7장 세포치료 및 유전자 치료 시장 분석 : 유형별
- 세포치료
- 유전자 치료
제8장 세포치료 및 유전자 치료 시장 분석 : 서비스별
- 프로세스 개발
- cGMP 제조
- 규제 서비스
- 바이오어세이 서비스
제9장 세포치료 및 유전자 치료 시장 분석 : 규모별
- 프리 커머셜/R&D 제조
- 상업 스케일 제조
제10장 세포치료 및 유전자 치료 시장 분석 : 서비스 프로바이더별
- CDMO
- CMO
제11장 세포치료 및 유전자 치료 시장 분석 : 최종사용자별
- 수탁 연구기관
- 제약·바이오의약품 기업
- 학술·연구기관
제12장 세포치료 및 유전자 치료 시장 : 지역별 분석
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
- 아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- APAC 기타 국가
- 중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 기타 중동 및 아프리카
- 중남미
- 브라질
- 아르헨티나
- 기타 중남미
제13장 업계 상황
- 세포치료 및 유전자 치료 시장에서 성장 전략
- 유기적 성장 전략
- 무기적 성장 전략
제14장 기업 개요
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Charles River Laboratories International Inc
- Cell and Gene Therapy Catapult
- Lonza Group AG
- WuXi AppTec Co Ltd
- Takara Bio Inc
- FUJIFILM Holdings Corp
- F. Hoffmann-La Roche Ltd
- Catalent Inc
- Lotte Corp
제15장 부록
KSA 24.10.10The cell and gene therapy market is expected to grow from US$ 4,485.00 million in 2023 to US$ 28,050.39 million by 2031; it is anticipated to record a CAGR of 25.8% from 2023 to 2031.
Key segments that contributed to the derivation of the cell and gene therapy market analysis are services, scale, service providers, and end user.
The cell and gene therapy market, by type, the cell and gene therapy market is segmented into bifurcated into cell therapy, gene therapy. The cell therapy segment held a larger market share in 2023. Cell therapy helps treat disorders and diseases by restoring or changing certain groups of cells or providing cells to carry therapy through the body. Cell therapy forms or modifies cells outside the body before introducing into the patient. The cells might derive from the patient (autologous cells) or a donor (allogeneic cells). The growth of the cell therapy segment is attributed to the increasing number of products entering the market, the potential application of cell therapies in treating autoimmune diseases, cancer, and infectious diseases, and the high number of ongoing clinical trials.
The cell and gene therapy market, by services, the market is segmented into process development, cGMP manufacturing, regulatory services, bioassay services. The process development segment held a larger share of the market in 2023. The cell and gene therapy market is witnessing rapid growth driven by technological advancements, particularly in manufacturing and delivery services. With such advancements, cell and gene therapy developers offer expertise in developing robust and scalable manufacturing processes, ensuring high-quality product consistency, and optimizing delivery methods for specific therapeutic targets.
By type, the market is segmented into vented and non-vented. The vented segment held a larger share of the market in 2023.
The cell and gene therapy market, by scale, the market is bifurcated into pre commercial/R and D manufacturing, commercial scale manufacturing. The pre commercial/R and D manufacturing segment held a larger share of the market in 2023.
The cell and gene therapy market, by service provider, the market is divided into CDMOs, CMOs. The CDMOs segment held a larger share of the market in 2023.
The cell and gene therapy market, by end user, the market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, academic and research institutes. The pharmaceutical and biopharmaceutical companies segment dominated the market in 2023.
The scope of the cell and gene therapy market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). In terms of revenue, North America accounted for the largest market share in 2023. On the other hand, Asia Pacific region accounted for the fastest-growing global cell and gene therapy market in 2023. China is making progress in gene and cell therapy. The country has a large patient population making it an attractive market for companies developing these treatments. Several companies are working on innovative therapies for diseases such as cancer and genetic disorders in China, and the country has invested heavily in gene therapy research and development. China was the first country to approve gene therapy in 2003; since then, cell and gene therapy developments have advanced rapidly worldwide, and their therapeutic potential has soared. The government of the People's Republic of China has conducted several regulatory reforms to promote the normative development of cell and gene therapies. In addition, the presence of various market leaders operating in the segments is contributing to the market expansion, which contribute notably to the expansion of cell and gene therapy market size.
European Union (EU), Organisation for Economic Co-operation and Development (OECD), and National Library of Medicine (NLM) are a few key primary and secondary sources referred to while preparing the report on the cell and gene therapy market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Cell and Gene Therapy Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
5. Cell and Gene Therapy Market - Key Market Dynamics
- 5.1 Cell and Gene Therapy Market - Key Market Dynamics
- 5.2 Market Drivers
- 5.2.1 Increase in Number of Approval of Cell and Gene Therapies
- 5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
- 5.3 Market Restraints
- 5.3.1 High Cost of Cell and Gene Therapy Manufacturing
- 5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Companies
- 5.5 Future Trends
- 5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
- 5.6 Impact of Drivers and Restraints:
6. Cell and Gene Therapy Market - Global Market Analysis
- 6.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
- 6.2 Cell and Gene Therapy Market Forecast Analysis
7. Cell and Gene Therapy Market Analysis - by Type
- 7.1 Cell Therapy
- 7.1.1 Overview
- 7.1.2 Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 7.2 Gene Therapy
- 7.2.1 Overview
- 7.2.2 Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8. Cell and Gene Therapy Market Analysis - by Services
- 8.1 Process Development
- 8.1.1 Overview
- 8.1.2 Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 8.2 cGMP Manufacturing
- 8.2.1 Overview
- 8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 8.3 Regulatory Services
- 8.3.1 Overview
- 8.3.2 Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 8.4 Bioassay Services
- 8.4.1 Overview
- 8.4.2 Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9. Cell and Gene Therapy Market Analysis - by Scale
- 9.1 Pre Commercial/R and D Manufacturing
- 9.1.1 Overview
- 9.1.2 Pre Commercial/R and D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2 Commercial Scale Manufacturing
- 9.2.1 Overview
- 9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10. Cell and Gene Therapy Market Analysis - by Service Providers
- 10.1 CDMOs
- 10.1.1 Overview
- 10.1.2 CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2 CMOs
- 10.2.1 Overview
- 10.2.2 CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11. Cell and Gene Therapy Market Analysis - by End User
- 11.1 Contract Research Organizations
- 11.1.1 Overview
- 11.1.2 Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 11.2 Pharmaceutical and Biopharmaceutical Companies
- 11.2.1 Overview
- 11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 11.3 Academic and Research Institutes
- 11.3.1 Overview
- 11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12. Cell and Gene Therapy Market - Geographical Analysis
- 12.1 Overview
- 12.2 North America
- 12.2.1 North America Cell and Gene Therapy Market Overview
- 12.2.2 North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.2.3 North America: Cell and Gene Therapy Market Breakdown, by Type
- 12.2.3.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
- 12.2.3.1.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
- 12.2.3.1.2 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.2.3.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
- 12.2.4 North America: Cell and Gene Therapy Market Breakdown, by Services
- 12.2.4.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.2.5 North America: Cell and Gene Therapy Market Breakdown, by Scale
- 12.2.5.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.2.6 North America: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.2.6.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.2.7 North America: Cell and Gene Therapy Market Breakdown, by End User
- 12.2.7.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.2.8 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
- 12.2.8.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
- 12.2.8.2 United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.2.8.2.1 United States: Cell and Gene Therapy Market Breakdown, by Type
- 12.2.8.2.1.1 United States: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.2.8.2.1.2 United States: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.2.8.2.2 United States: Cell and Gene Therapy Market Breakdown, by Services
- 12.2.8.2.3 United States: Cell and Gene Therapy Market Breakdown, by Scale
- 12.2.8.2.4 United States: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.2.8.2.5 United States: Cell and Gene Therapy Market Breakdown, by End User
- 12.2.8.3 Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.2.8.3.1 Canada: Cell and Gene Therapy Market Breakdown, by Type
- 12.2.8.3.1.1 Canada: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.2.8.3.1.2 Canada: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.2.8.3.2 Canada: Cell and Gene Therapy Market Breakdown, by Services
- 12.2.8.3.3 Canada: Cell and Gene Therapy Market Breakdown, by Scale
- 12.2.8.3.4 Canada: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.2.8.3.5 Canada: Cell and Gene Therapy Market Breakdown, by End User
- 12.2.8.4 Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.2.8.4.1 Mexico: Cell and Gene Therapy Market Breakdown, by Type
- 12.2.8.4.1.1 Mexico: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.2.8.4.1.2 Mexico: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.2.8.4.2 Mexico: Cell and Gene Therapy Market Breakdown, by Services
- 12.2.8.4.3 Mexico: Cell and Gene Therapy Market Breakdown, by Scale
- 12.2.8.4.4 Mexico: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.2.8.4.5 Mexico: Cell and Gene Therapy Market Breakdown, by End User
- 12.3 Europe
- 12.3.1 Europe Cell and Gene Therapy Market Overview
- 12.3.2 Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.3 Europe: Cell and Gene Therapy Market Breakdown, by Type
- 12.3.3.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
- 12.3.3.1.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
- 12.3.3.1.2 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.3.3.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
- 12.3.4 Europe: Cell and Gene Therapy Market Breakdown, by Services
- 12.3.4.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.3.5 Europe: Cell and Gene Therapy Market Breakdown, by Scale
- 12.3.5.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.3.6 Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.3.6.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.3.7 Europe: Cell and Gene Therapy Market Breakdown, by End User
- 12.3.7.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.3.8 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
- 12.3.8.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
- 12.3.8.2 United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.8.2.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Type
- 12.3.8.2.1.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.3.8.2.1.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.3.8.2.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Services
- 12.3.8.2.3 United Kingdom: Cell and Gene Therapy Market Breakdown, by Scale
- 12.3.8.2.4 United Kingdom: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.3.8.2.5 United Kingdom: Cell and Gene Therapy Market Breakdown, by End User
- 12.3.8.3 Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.8.3.1 Germany: Cell and Gene Therapy Market Breakdown, by Type
- 12.3.8.3.1.1 Germany: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.3.8.3.1.2 Germany: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.3.8.3.2 Germany: Cell and Gene Therapy Market Breakdown, by Services
- 12.3.8.3.3 Germany: Cell and Gene Therapy Market Breakdown, by Scale
- 12.3.8.3.4 Germany: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.3.8.3.5 Germany: Cell and Gene Therapy Market Breakdown, by End User
- 12.3.8.4 France: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.8.4.1 France: Cell and Gene Therapy Market Breakdown, by Type
- 12.3.8.4.1.1 France: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.3.8.4.1.2 France: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.3.8.4.2 France: Cell and Gene Therapy Market Breakdown, by Services
- 12.3.8.4.3 France: Cell and Gene Therapy Market Breakdown, by Scale
- 12.3.8.4.4 France: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.3.8.4.5 France: Cell and Gene Therapy Market Breakdown, by End User
- 12.3.8.5 Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.8.5.1 Italy: Cell and Gene Therapy Market Breakdown, by Type
- 12.3.8.5.1.1 Italy: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.3.8.5.1.2 Italy: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.3.8.5.2 Italy: Cell and Gene Therapy Market Breakdown, by Services
- 12.3.8.5.3 Italy: Cell and Gene Therapy Market Breakdown, by Scale
- 12.3.8.5.4 Italy: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.3.8.5.5 Italy: Cell and Gene Therapy Market Breakdown, by End User
- 12.3.8.6 Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.8.6.1 Spain: Cell and Gene Therapy Market Breakdown, by Type
- 12.3.8.6.1.1 Spain: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.3.8.6.1.2 Spain: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.3.8.6.2 Spain: Cell and Gene Therapy Market Breakdown, by Services
- 12.3.8.6.3 Spain: Cell and Gene Therapy Market Breakdown, by Scale
- 12.3.8.6.4 Spain: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.3.8.6.5 Spain: Cell and Gene Therapy Market Breakdown, by End User
- 12.3.8.7 Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.8.7.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Type
- 12.3.8.7.1.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.3.8.7.1.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.3.8.7.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Services
- 12.3.8.7.3 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Scale
- 12.3.8.7.4 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.3.8.7.5 Rest of Europe: Cell and Gene Therapy Market Breakdown, by End User
- 12.4 Asia Pacific
- 12.4.1 Asia Pacific Cell and Gene Therapy Market Overview
- 12.4.2 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.3 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Type
- 12.4.3.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
- 12.4.3.1.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
- 12.4.3.1.2 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.4.3.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
- 12.4.4 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Services
- 12.4.4.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.4.5 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Scale
- 12.4.5.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.4.6 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.4.6.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.4.7 Asia Pacific: Cell and Gene Therapy Market Breakdown, by End User
- 12.4.7.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.4.8 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
- 12.4.8.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
- 12.4.8.2 China: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.8.2.1 China: Cell and Gene Therapy Market Breakdown, by Type
- 12.4.8.2.1.1 China: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.4.8.2.1.2 China: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.4.8.2.2 China: Cell and Gene Therapy Market Breakdown, by Services
- 12.4.8.2.3 hina: Cell and Gene Therapy Market Breakdown, by Scale
- 12.4.8.2.4 China: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.4.8.2.5 China: Cell and Gene Therapy Market Breakdown, by End User
- 12.4.8.3 Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.8.3.1 Japan: Cell and Gene Therapy Market Breakdown, by Type
- 12.4.8.3.1.1 Japan: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.4.8.3.1.2 Japan: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.4.8.3.2 Japan: Cell and Gene Therapy Market Breakdown, by Services
- 12.4.8.3.3 Japan: Cell and Gene Therapy Market Breakdown, by Scale
- 12.4.8.3.4 Japan: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.4.8.3.5 Japan: Cell and Gene Therapy Market Breakdown, by End User
- 12.4.8.4 India: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.8.4.1 India: Cell and Gene Therapy Market Breakdown, by Type
- 12.4.8.4.1.1 India: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.4.8.4.1.2 India: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.4.8.4.2 India: Cell and Gene Therapy Market Breakdown, by Services
- 12.4.8.4.3 India: Cell and Gene Therapy Market Breakdown, by Scale
- 12.4.8.4.4 India: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.4.8.4.5 India: Cell and Gene Therapy Market Breakdown, by End User
- 12.4.8.5 Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.8.5.1 Australia: Cell and Gene Therapy Market Breakdown, by Type
- 12.4.8.5.1.1 Australia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.4.8.5.1.2 Australia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.4.8.5.2 Australia: Cell and Gene Therapy Market Breakdown, by Services
- 12.4.8.5.3 Australia: Cell and Gene Therapy Market Breakdown, by Scale
- 12.4.8.5.4 Australia: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.4.8.5.5 Australia: Cell and Gene Therapy Market Breakdown, by End User
- 12.4.8.6 South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.8.6.1 South Korea: Cell and Gene Therapy Market Breakdown, by Type
- 12.4.8.6.1.1 South Korea: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.4.8.6.1.2 South Korea: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.4.8.6.2 South Korea: Cell and Gene Therapy Market Breakdown, by Services
- 12.4.8.6.3 South Korea: Cell and Gene Therapy Market Breakdown, by Scale
- 12.4.8.6.4 South Korea: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.4.8.6.5 South Korea: Cell and Gene Therapy Market Breakdown, by End User
- 12.4.8.7 Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.8.7.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Type
- 12.4.8.7.1.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.4.8.7.1.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.4.8.7.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Services
- 12.4.8.7.3 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Scale
- 12.4.8.7.4 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.4.8.7.5 Rest of APAC: Cell and Gene Therapy Market Breakdown, by End User
- 12.5 Middle East and Africa
- 12.5.1 Middle East and Africa Cell and Gene Therapy Market Overview
- 12.5.2 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.5.3 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
- 12.5.3.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
- 12.5.3.1.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
- 12.5.3.1.2 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.5.3.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
- 12.5.4 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
- 12.5.4.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.5.5 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
- 12.5.5.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.5.6 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.5.6.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.5.7 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
- 12.5.7.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.5.8 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
- 12.5.8.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
- 12.5.8.2 South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.5.8.2.1 South Africa: Cell and Gene Therapy Market Breakdown, by Type
- 12.5.8.2.1.1 South Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.5.8.2.1.2 South Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.5.8.2.2 South Africa: Cell and Gene Therapy Market Breakdown, by Services
- 12.5.8.2.3 South Africa: Cell and Gene Therapy Market Breakdown, by Scale
- 12.5.8.2.4 South Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.5.8.2.5 South Africa: Cell and Gene Therapy Market Breakdown, by End User
- 12.5.8.3 Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.5.8.3.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Type
- 12.5.8.3.1.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.5.8.3.1.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.5.8.3.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Services
- 12.5.8.3.3 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Scale
- 12.5.8.3.4 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.5.8.3.5 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by End User
- 12.5.8.4 United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.5.8.4.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Type
- 12.5.8.4.1.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.5.8.4.1.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.5.8.4.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Services
- 12.5.8.4.3 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Scale
- 12.5.8.4.4 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.5.8.4.5 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by End User
- 12.5.8.5 Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.5.8.5.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
- 12.5.8.5.1.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.5.8.5.1.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.5.8.5.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
- 12.5.8.5.3 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
- 12.5.8.5.4 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.5.8.5.5 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
- 12.6 South and Central America
- 12.6.1 South and Central America Cell and Gene Therapy Market Overview
- 12.6.2 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.6.3 South and Central America: Cell and Gene Therapy Market Breakdown, by Type
- 12.6.3.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
- 12.6.3.1.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
- 12.6.3.1.2 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.6.3.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
- 12.6.4 South and Central America: Cell and Gene Therapy Market Breakdown, by Services
- 12.6.4.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.6.5 South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
- 12.6.5.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.6.6 South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.6.6.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.6.7 South and Central America: Cell and Gene Therapy Market Breakdown, by End User
- 12.6.7.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.6.8 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
- 12.6.8.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
- 12.6.8.2 Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.6.8.2.1 Brazil: Cell and Gene Therapy Market Breakdown, by Type
- 12.6.8.2.1.1 Brazil: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.6.8.2.1.2 Brazil: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.6.8.2.2 Brazil: Cell and Gene Therapy Market Breakdown, by Services
- 12.6.8.2.3 Brazil: Cell and Gene Therapy Market Breakdown, by Scale
- 12.6.8.2.4 Brazil: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.6.8.2.5 Brazil: Cell and Gene Therapy Market Breakdown, by End User
- 12.6.8.3 Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.6.8.3.1 Argentina: Cell and Gene Therapy Market Breakdown, by Type
- 12.6.8.3.1.1 Argentina: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.6.8.3.1.2 Argentina: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.6.8.3.2 Argentina: Cell and Gene Therapy Market Breakdown, by Services
- 12.6.8.3.3 Argentina: Cell and Gene Therapy Market Breakdown, by Scale
- 12.6.8.3.4 Argentina: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.6.8.3.5 Argentina: Cell and Gene Therapy Market Breakdown, by End User
- 12.6.8.4 Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.6.8.4.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Type
- 12.6.8.4.1.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Cell Therapy
- 12.6.8.4.1.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Gene Therapy
- 12.6.8.4.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Services
- 12.6.8.4.3 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
- 12.6.8.4.4 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
- 12.6.8.4.5 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by End User
13. Industry Landscape
- 13.1 Overview
- 13.2 Growth Strategies in Cell and Gene Therapy Market
- 13.3 Organic Growth Strategies
- 13.3.1 Overview
- 13.4 Inorganic Growth Strategies
- 13.4.1 Overview
14. Company Profiles
- 14.1 Thermo Fisher Scientific Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
- 14.2 Merck KGaA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
- 14.3 Charles River Laboratories International Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
- 14.4 Cell and Gene Therapy Catapult
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
- 14.5 Lonza Group AG
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
- 14.6 WuXi AppTec Co Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
- 14.7 Takara Bio Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
- 14.8 FUJIFILM Holdings Corp
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
- 14.9 F. Hoffmann-La Roche Ltd
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
- 14.10 Catalent Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
- 14.11 Lotte Corp
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
15. Appendix
- 15.1 About The Insight Partners
- 15.2 Glossary of Terms
샘플 요청 목록